Holdings

Stonepine Capital Management, LLC

As of Sep 30, 2026, Stonepine Capital Management, LLC reported 61 positions worth US$116M. Largest: Verastem, Inc., CAMP4 Therapeutics Corporation and Evolus, Inc. Common Stock. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Verastem, Inc.3.04MUS$24.5M−307KSep 30, 2026
CAMP4 Therapeutics Corporation2.79MUS$11.3M+1.4MSep 30, 2026
Evolus, Inc. Common Stock972KUS$7.77M−619KSep 30, 2026
ADMA Biologics Inc700KUS$7.02M−40,000Sep 30, 2026
Nektar Therapeutics110KUS$6.66M−10,654Sep 30, 2026
Eloxx Pharmaceuticals, Inc.382KUS$5.85M−15,183Sep 30, 2026
Satellos Bioscience Inc455KUS$3.87M−36,566Sep 30, 2026
Kazia Therapeutics Ltd377KUS$3.62MnewSep 30, 2026
Indivior Pharmaceuticals, Inc.100KUS$3.58Mno changeSep 30, 2026
Ultragenyx Pharmaceutical Inc.210KUS$3.16M+185KSep 30, 2026